Effect of Individual Cognitive Stimulation on Memory and Executive Function in Older Adults With Alzheimer's Disease
1 other identifier
interventional
142
1 country
14
Brief Summary
This multicentre study, with a randomised controlled repeated measures experimental design, will be conducted in several Portuguese institutions, which provide care and supportive services for older adults diagnosed with mild or moderate Alzheimer's disease (AD), with an aim to assess the effect of individual cognitive stimulation (CS) on memory and executive functioning. Participants in the intervention group will attend 24 individual CS sessions, twice weekly for 12 weeks. Participants in the control group will complete their usual routines without any activity restrictions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2022
CompletedFirst Posted
Study publicly available on registry
June 27, 2022
CompletedStudy Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 6, 2023
CompletedOctober 16, 2023
July 1, 2022
9 months
June 22, 2022
October 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (18)
Cognitive functioning assessed through Mini-Mental State Examination (MMSE)
Cognitive functioning assessed by the Mini-Mental State Examination (MMSE), a gold standard screening tool for assessing global cognitive function. Scores range from 0 to 30, with higher scores indicating better cognitive functioning.
baseline
Change in cognitive functioning assessed through Mini-Mental State Examination (MMSE)
Change in cognitive functioning evaluated by the Mini-Mental State Examination (MMSE), a gold standard screening tool for assessing global cognitive function. Scores range from 0 to 30, with higher scores indicating better cognitive functioning.
12 weeks after the beginning of the intervention
Change in cognitive functioning assessed through Mini-Mental State Examination (MMSE)
Change in cognitive functioning evaluated by the Mini-Mental State Examination (MMSE), a gold standard screening tool for assessing global cognitive function. Scores range from 0 to 30, with higher scores indicating better cognitive functioning.
12 weeks after end of intervention
Cognitive functioning assessed through Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-COG)
Evaluates the severity of cognitive deficits in AD in the following domains: memory, orientation, language, praxis and constructive capacity. The total score in the Portuguese version of ADAS-Cog is composed of 11 subtests in the cognitive part and varies between 0 (better performance) and 68 points (worse performance), i.e., higher scores equals better performance.
baseline
Change in cognitive functioning assessed through Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-COG)
Evaluates the severity of cognitive deficits in AD in the following domains: memory, orientation, language, praxis and constructive capacity. The total score in the Portuguese version of ADAS-Cog is composed of 11 subtests in the cognitive part and varies between 0 (better performance) and 68 points (worse performance), i.e., higher scores equals better performance.
12 weeks after the beginning of the intervention
Change in cognitive functioning assessed through Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-COG)
Evaluates the severity of cognitive deficits in AD in the following domains: memory, orientation, language, praxis and constructive capacity. The total score in the Portuguese version of ADAS-Cog is composed of 11 subtests in the cognitive part and varies between 0 (better performance) and 68 points (worse performance), i.e., higher scores equals better performance.
12 weeks after end of intervention
Memory function evaluated through Memory Alteration Test (MAT)
The MAT is used to assess memory function. It is an easy and quick instrument that assesses five memory domains: temporal orientation, encoding, semantic memory, free recall, and cued recall. Total scores range from 0 to 50, with higher scores indicating better memory. It has good psychometric properties and is highly sensitive to mild cognitive decline.
baseline
Change in memory function evaluated through Memory Alteration Test (MAT)
The MAT is used to assess memory function. It is an easy and quick instrument that assesses five memory domains: temporal orientation, encoding, semantic memory, free recall, and cued recall. Total scores range from 0 to 50, with higher scores indicating better memory. It has good psychometric properties and is highly sensitive to mild cognitive decline.
12 weeks after the beginning of the intervention
Change in memory function evaluated through Memory Alteration Test (MAT)
The MAT is used to assess memory function. It is an easy and quick instrument that assesses five memory domains: temporal orientation, encoding, semantic memory, free recall, and cued recall. Total scores range from 0 to 50, with higher scores indicating better memory. It has good psychometric properties and is highly sensitive to mild cognitive decline.
12 weeks after end of intervention
Memory function evaluated through Free and Cued Selective Reminding Test (FCSRT)
FCSRT is a verbal learning and memory test that allows prompting the encoding and retrieval conditions by using semantic cues on learning and recall trials. It is composed of 16 semantically categorised, unrelated items/words.
baseline
Change in memory function evaluated through Free and Cued Selective Reminding Test (FCSRT)
FCSRT is a verbal learning and memory test that allows prompting the encoding and retrieval conditions by using semantic cues on learning and recall trials. It is composed of 16 semantically categorised, unrelated items/words.
12 weeks after the beginning of the intervention
Change in memory function evaluated through Free and Cued Selective Reminding Test (FCSRT)
FCSRT is a verbal learning and memory test that allows prompting the encoding and retrieval conditions by using semantic cues on learning and recall trials. It is composed of 16 semantically categorised, unrelated items/words.
12 weeks after end of intervention
Executive functions assessed through Frontal Assessment Battery (FAB)
FAB assesses executive functions such as abstract thinking, mental flexibility, motor programming, interference sensibility, inhibitory control and environmental independence. Scores range between 0 - 18 points with higher scores indicating better cognitive function.
baseline
Change in executive functions assessed through Frontal Assessment Battery (FAB)
FAB assesses executive functions such as abstract thinking, mental flexibility, motor programming, interference sensibility, inhibitory control and environmental independence. Scores range between 0 - 18 points with higher scores indicating better cognitive function.
12 weeks after the beginning of the intervention
Change in executive functions assessed through Frontal Assessment Battery (FAB)
FAB assesses executive functions such as abstract thinking, mental flexibility, motor programming, interference sensibility, inhibitory control and environmental independence. Scores range between 0 - 18 points with higher scores indicating better cognitive function.
12 weeks after end of intervention
Executive functions assessed through Trail Making Test (TMT)
TMT is one of the most widely used instruments in clinical and experimental neuropsychology. It is very sensitive to identify cognitive impairments, measuring simple motor and spatial skills, basic sequencing skills, mental flexibility, selective attention, visuo-perceptual skills, motor speed, and executive functions. Higher scores indicate greater impairment.
baseline
Change in executive functions assessed through Trail Making Test (TMT)
TMT is one of the most widely used instruments in clinical and experimental neuropsychology. It is very sensitive to identify cognitive impairments, measuring simple motor and spatial skills, basic sequencing skills, mental flexibility, selective attention, visuo-perceptual skills, motor speed, and executive functions. Higher scores indicate greater impairment.
12 weeks after the beginning of the intervention
Change in executive functions assessed through Trail Making Test (TMT)
TMT is one of the most widely used instruments in clinical and experimental neuropsychology. It is very sensitive to identify cognitive impairments, measuring simple motor and spatial skills, basic sequencing skills, mental flexibility, selective attention, visuo-perceptual skills, motor speed, and executive functions. Higher scores indicate greater impairment.
12 weeks after end of intervention
Other Outcomes (2)
Sociodemographic information gathered through the sociodemographic questionnaire
baseline
Adherence to the intervention and dropouts evaluated through a session form
during the intervention
Study Arms (2)
Intervention group
EXPERIMENTALParticipants who meet the inclusion criteria will be randomly assigned to the intervention group receiving individual CS or to the control group receiving treatment as usual (participating in the activities previously established in their individual intervention plan). Participants in the intervention group will participate in two individual CS sessions per week for 12 weeks in addition to their treatment as usual. The sessions will include the same protocol in every participant site.
Control group
NO INTERVENTIONParticipants in the control group will receive treatment/activities as usual, participating in the activities previously established in their individual intervention plan.
Interventions
The intervention program will have 24 sessions (base scheme of 4 series of 6 sessions), lasting approximately 45 min and will be developed according to the following structure: - welcoming (greeting to the participant) (5 min); - orientation to reality (10 min); - main cognitive stimulation activity (25 min); - return to calm and evaluation of the session (5 min). The CS sessions will have an individual format and will be conducted by a professional with experience in CS and previously trained in this intervention. The intervention sessions will include several activities based on the CS principles, with evidence suggesting positive participant effects. The CS sessions will be carried out using material, developed by the principal investigator, in digital format (power point presentations). There will be no repetition of activities, and throughout the base CS program, the degree of difficulty of the exercises will be adjusted based on the dementia stage of the participant.
Eligibility Criteria
You may qualify if:
- Age 65 or over.
- Receive care and support services for older adults for at least three months.
- Alzheimer's disease, according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition.
- Ability to communicate and understand.
- Native speakers of Portuguese.
- To have given informed consent for the project, duly completed and signed, after previous information.
- Total scores between 10 and 24 points on the Mini Mental State Examination.
You may not qualify if:
- Cannot read and write.
- Severe sensory and physical limitations and/or an acute or serious illness preventing participation in the CS sessions.
- Evidence of aggressive and disruptive behaviour, as indicated by the reference technicians of the institution to which the participant is linked.
- Consumption of psychoactive substances, taking neuroleptics and/or antipsychotics in the last two months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rsocialform - Geriatria, Ldalead
- Aveiro Universitycollaborator
Study Sites (14)
Rsocialform - Geriatria, Lda
Mealhada, Aveiro District, 3050, Portugal
Santa Casa da Misericórdia da Horta
Açores, Portugal
Cediara - Associação de Solidariedade Social de Ribeira de Fráguas
Aveiro, Portugal
Centro Social e Cultural S. Pedro de Bairro
Braga, Portugal
Centro Social Vale do Homem - Casa da Alegria
Braga, Portugal
Santa Casa da Misericórdia de Castro Marim
Faro, Portugal
Fundação João Bento Raimundo
Guarda, Portugal
Santa Casa da Misericórdia de Alcobaça
Leiria, Portugal
Associação de Socorros da Freguesia de Turcifal
Lisbon, Portugal
Centro de Apoio Social de Oeiras - IASFA
Lisbon, Portugal
Inválidos do Comércio
Lisbon, Portugal
Associação de Apoio Social de Perafita
Porto, Portugal
Santa Casa da Misericórdia de Coruche
Santarém, Portugal
Santa Casa da Misericórdia de Ponte de Lima
Viana do Castelo, Portugal
Related Publications (1)
Justo-Henriques SI, Lemos R, Rahmatpour P, Silva RCG, Carvalho JO, Ribeiro O. Effectiveness of Individual Cognitive Stimulation on Cognition in Mild Alzheimer's Disease: A Multicenter RCT. Psychogeriatrics. 2025 Nov;25(6):e70109. doi: 10.1111/psyg.70109.
PMID: 41139428DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susana I Justo Henriques, PhD
Nursing School of Coimbra
- STUDY DIRECTOR
Óscar Ribeiro, PhD
Aveiro University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Double (Participant, Outcomes Assessor)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2022
First Posted
June 27, 2022
Study Start
July 1, 2022
Primary Completion
March 31, 2023
Study Completion
October 6, 2023
Last Updated
October 16, 2023
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share